REQUEST A DEMO
Total
USD $0.00
Search more companies

Gmup Apteka N21 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Gmup Apteka N21 Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Gmup Apteka N21 is a company based in Russia, with its head office in Georgievsk. It operates in the Pharmacies and Drug Stores industry. Gmup Apteka N21 was incorporated on June 07, 2024. There was a net sales revenue increase of 1.86% reported in Gmup Apteka N21’s latest financial highlights for 2023. Its’ total assets recorded a growth of 6.93%. The enterprise’s net profit margin decreased by 0.34% in 2023.

Headquarters
Pushkina, 56
Georgievsk; Stavropol Krai; Postal Code: 357820

Contact Details: Purchase the Gmup Apteka N21 report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gmup Apteka N21 report to view the information.
Registered Capital:
Purchase the Gmup Apteka N21 report to view the information.
Incorporation Date:
June 07, 2024
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Gmup Apteka N21 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
1.86%
Total operating revenue
1.86%
Operating profit (EBIT)
14.66%
Net Profit (Loss) for the Period
-9.18%
Total assets
6.93%
Total equity
15.93%
Operating Profit Margin (ROS)
0.47%
Net Profit Margin
-0.34%
Return on Equity (ROE)
-11.86%
Quick Ratio
-0.01%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?